This implies that p53 inactivation in association with other oncogenes, for example BRAFV600E, induces a malignant phenotype in thyrocytes with loss of differentiation and, therefore, is crucial in late-stage progression of thyroid cancer. This evidence concerns the gene TP53 and thyroid cancer.